PTCT
PTC Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$69.30
−2.94%Forward multiples
Based on analyst estimates
- P/E forward
- 57.35x
- P/E 2026E
- 56.07x
- P/E 2027E
- 26.11x
- P/E 2028E
- 14.26x
- P/S forward
- 4.64x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -34.98x
- Price / sales
- 5.73x
- Price / cash flow
- -189.62x
Enterprise value
- Enterprise value
- $4.3B
- EV / sales
- 4.21x
- EV / EBITDA
- 24.50x
- EV / EBIT
- 36.57x
- Market cap
- $5.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026